Cadila Healthcare has reported results for third quarter ended December 31, 2020.
The company has reported a fall of 34.32% in its net profit at Rs 140.30 crore for the quarter under review as compared to Rs 213.60 crore for the same quarter in the previous year. However, total income of the company increased by 11.67% at Rs 1,943.80 crore for Q3FY21 as compared Rs 1,740.70 crore for the corresponding quarter previous year.
On the consolidated basis, the company has reported a rise of 41% in its net profit at Rs 527.20 crore for the quarter under review as compared to Rs 373.90 crore for the same quarter in the previous year. Total income of the company increased by 4.51% at Rs 3,823.10 crore for Q3FY21 as compared Rs 3,658.20 crore for the corresponding quarter previous year.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1483.75 |
Dr. Reddys Lab | 5947.30 |
Cipla | 1347.70 |
Zydus Lifesciences | 958.90 |
Lupin | 1580.00 |
View more.. |